Company / Interest Expense
Neogen Interest Expense History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$38.1M
FY2024
5-year range
$27.3M / $42.2M
FY2022-FY2024
Trend
-9.6%
vs FY2023
Sector context
#27 of 40
Health Care
What the data says
At $38M, Neogen's interest expense ranks #14 of 40 in the Health Care sector. Increased from $27M to $38M over the past 2 years.
Based on SEC 10-K filings.
$38M in FY2024.
Increased from $27M to $38M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#14 of 40 in Health CareTop 32% of 40This company $38.1M Sector average $332.7M
▼
-88.5% below sector average
Key checks
Key Insights
- In FY2024, interest expense decreased 9.6% year-over-year.
- Ranks #27 out of 40 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $38.1M | -9.6% |
| FY2023 | $42.2M | +54.7% |
| FY2022 | $27.3M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026